Sign in
DNA Stock Price, Chart, Stats & News
Ginkgo Bioworks Holdings
Save
Ginkgo Bioworks Holdings (DNA) does not currently pay a dividend.
515.41M
Market cap
–
Current P/E
–
Forward P/E
DNA chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 81.48% |
Operating margin | -185.29% |
Pretax margin | -184.30% |
Net margin | -183.81% |
Effective tax rate | 0.27% |
ROA | -27.93% |
ROE | -53.72% |
D/E | 0.82x |
Interest coverage ratio | – |
DNA valuation
P/E | – |
P/S | 2.16x |
P/B | 0.65x |
P/CF | -1.92x |
P/FCF | -1.89x |
P/OCF | -1.92x |
PEG | -0.10x |
EV multiple | -0.54x |
About
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics, antibody developability, and small molecule developability, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products.
Similar securities
Based on sector and market capitalization
Report issue